Heparan sulfate 3-O-sulfation: A rare modification in search of a function

Matrix Biology

Volumn 35, Issue , 2014, Pages 60-72

  Thacker, Bryan E ^a   Xu, Ding ^a   Lawrence, Roger ^a   Esko, Jeffrey D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3 O Sulfotransferases; Antithrombin; Growth factors; Heparan sulfate; Sulfation

Indexed keywords

ANTITHROMBIN; CYCLOPHILIN B; FIBROBLAST GROWTH FACTOR; GLYCOPROTEIN D; HEPARAN SULFATE; SULFOTRANSFERASE; VIRUS GLYCOPROTEIN; CYCLOPHILIN; GLYCOPROTEIN D, HUMAN HERPESVIRUS 1; OLIGOSACCHARIDE; SULFATE; URONIC ACID; VIRUS ENVELOPE PROTEIN;

ARTICLE; CRYSTAL STRUCTURE; ENZYME MODIFICATION; ENZYME SPECIFICITY; HERPES SIMPLEX VIRUS; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SULFATION; ANIMAL; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR EVOLUTION; PHYLOGENY; SPECIES DIFFERENCE;

MAMMALIA; SIMPLEXVIRUS;

ANIMALS; ANTITHROMBINS; BINDING SITES; CYCLOPHILINS; EVOLUTION, MOLECULAR; HEPARITIN SULFATE; HUMANS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; OLIGOSACCHARIDES; PHYLOGENY; SPECIES SPECIFICITY; SULFATES; SULFOTRANSFERASES; URONIC ACIDS; VIRAL ENVELOPE PROTEINS;

EID: 84901404021     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2013.12.001     Document Type: Article

References (149)

1. Allain F., Vanpouille C., Carpentier M., Slomianny M.C., Durieux S., Spik G. Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:2714-2719.
2. Arungundram S., Al-Mafraji K., Asong J., Leach F.E., Amster I.J., Venot A., Turnbull J.E., Boons G.J. Modular synthesis of heparan sulfate oligosaccharides for structure-activity relationship studies. J. Am. Chem. Soc. 2009, 131:17394-17405.
3. Atha D.H., Lormeau J.C., Petitou M., Rosenberg R.D., Choay J. Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry 1985, 24:6723-6729.
4. Atha D.H., Lormeau J.C., Petitou M., Rosenberg R.D., Choay J. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III. Biochemistry 1987, 26:6454-6461.
5. Atkinson A., Garnier S., Afridi S., Fumoux F., Rihet P. Genetic variations in genes involved in heparan sulphate biosynthesis are associated with Plasmodium falciparum parasitaemia: a familial study in Burkina Faso. Malar. J. 2012, 11:108.
6. Attreed M., Desbois M., van Kuppevelt T.H., Bulow H.E. Direct visualization of specifically modified extracellular glycans in living animals. Nat. Methods 2012, 9:477-479.
7. Bienkowski M.J., Conrad H.E. Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid. J Biol Chem. 1985, 260:356-365.
8. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
9. Borjigin J., Deng J., Sun X., De Jesus M., Liu T., Wang M.M. Diurnal pineal 3-O-sulphotransferase 2 expression controlled by beta-adrenergic repression. J. Biol. Chem. 2003, 278:16315-16319.
10. Boven L.A., Noorbakhsh F., Bouma G., van der Zee R., Vargas D.L., Pardo C., McArthur J.C., Nottet H.S., Power C. Brain-derived human immunodeficiency virus-1 Tat exerts differential effects on LTR transactivation and neuroimmune activation. J. Neurovirol. 2007, 13:173-184.
11. Bui C., Ouzzine M., Talhaoui I., Sharp S., Prydz K., Coughtrie M.W., Fournel-Gigleux S. Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells. Faseb J. 2010, 24:436-450.
12. Cadwallader A.B., Yost H.J. Combinatorial expression patterns of heparan sulfate sulfotransferases in zebrafish: I. The 3-O-sulfotransferase family. Dev. Dyn. 2006, 235:3423-3431.
13. Carfi A., Willis S.H., Whitbeck J.C., Krummenacher C., Cohen G.H., Eisenberg R.J., Wiley D.C. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol. Cell 2001, 8:169-179.
14. Casu B., Oreste P., Torri G., Zoppetti G., Choay J., Lormeau J.C., Petitou M., Sinay P. The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies. Biochem J. 1981, 197:599-609.
15. Chen J., Liu J. Characterization of the structure of antithrombin-binding heparan sulfate generated by heparan sulfate 3-O-sulfotransferase 5. Biochim. Biophys. Acta 2005, 1725:190-200.
16. Chen J., Duncan M.B., Carrick K., Pope R.M., Liu J. Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5. Glycobiology 2003, 13:785-794.
17. Chen J., Jones C.L., Liu J. Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures. Chem. Biol. 2007, 14:986-993.
18. Choay J., Petitou M., Lormeau J.C., Sinay P., Casu B., Gatti G. Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem. Biophys. Res. Commun. 1983, 116:492-499.
19. Copeland R., Balasubramaniam A., Tiwari V., Zhang F., Bridges A., Linhardt R.J., Shukla D., Liu J. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 2008, 47:5774-5783.
20. de Agostini A., Watkins S.C., Slayter H.S., Youssoufian H., Rosenberg R.D. Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta. J. Cell Biol. 1990, 111:1293-1304.
21. de Agostini A.I., Dong J.C., de Vantery Arrighi C., Ramus M.A., Dentand-Quadri I., Thalmann S., Ventura P., Ibecheole V., Monge F., Fischer A.M., HajMohammadi S., Shworak N.W., Zhang L., Zhang Z., Linhardt R.J. Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity. J. Biol. Chem. 2008, 283:28115-28124.
22. Deligny A., Denys A., Marcant A., Melchior A., Mazurier J., van Kuppevelt T.H., Allain F. Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases. J. Biol. Chem. 2010, 285:1701-1715.
23. Desai U.R., Wang H., Ampofo S.A., Linhardt R.J. Oligosaccharide composition of heparin and low-molecular-weight heparins by capillary electrophoresis. Anal. Biochem. 1993, 213:120-127.
24. Dewerchin M., Herault J.P., Wallays G., Petitou M., Schaeffer P., Millet L., Weitz J.I., Moons L., Collen D., Carmeliet P., Herbert J.M. Life-threatening thrombosis in mice with targeted Arg48-to-Cys mutation of the heparin-binding domain of antithrombin. Circ. Res. 2003, 93:1120-1126.
25. Duncan M.B., Chen J., Krise J.P., Liu J. The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5. Biochim. Biophys. Acta 2004, 1671:34-43.
26. Edavettal S.C., Lee K.A., Negishi M., Linhardt R.J., Liu J., Pedersen L.C. Crystal structure and mutational analysis of heparan sulfate 3-O-sulfotransferase isoform 1. J. Biol. Chem. 2004, 279:25789-25797.
27. Edge A.S., Spiro R.G. Characterization of novel sequences containing 3-O-sulfated glucosamine in glomerular basement membrane heparan sulfate and localization of sulfated disaccharides to a peripheral domain. J. Biol. Chem. 1990, 265:15874-15881.
28. Esko J.D., Selleck S.B. Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 2002, 71:435-471.
29. Essner J.J., Amack J.D., Nyholm M.K., Harris E.B., Yost H.J. Kupffer's vesicle is a ciliated organ of asymmetry in the zebrafish embryo that initiates left-right development of the brain, heart and gut. Development 2005, 132:1247-1260.
30. Gandrille S., Aiach M., Lane D.A., Vidaud D., Molho-Sabatier P., Caso R., de Moerloose P., Fiessinger J.N., Clauser E. Important role of arginine 129 in heparin-binding site of antithrombin III. Identification of a novel mutation arginine 129 to glutamine. J. Biol. Chem. 1990, 265:18997-19001.
31. Girardin E.P., Hajmohammadi S., Birmele B., Helisch A., Shworak N.W., de Agostini A.I. Synthesis of anticoagulantly active heparan sulfate proteoglycans by glomerular epithelial cells involves multiple 3-O-sulfotransferase isoforms and a limiting precursor pool. J. Biol. Chem. 2005, 280:38059-38070.
32. Guerrini M., Guglieri S., Beccati D., Torri G., Viskov C., Mourier P. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III. Biochem J. 2006, 399:191-198.
33. Guerrini M., Guglieri S., Casu B., Torri G., Mourier P., Boudier C., Viskov C. Antithrombin-binding octasaccharides and role of extensions of the active pentasaccharide sequence in the specificity and strength of interaction. Evidence for very high affinity induced by an unusual glucuronic acid residue. J. Biol. Chem. 2008, 283:26662-26675.
34. Guerrini M., Elli S., Mourier P., Rudd T.R., Gaudesi D., Casu B., Boudier C., Torri G., Viskov C. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence. Biochem. J. 2013, 449:343-351.
35. HajMohammadi S., Enjyoji K., Princivalle M., Christi P., Lech M., Beeler D., Rayburn H., Schwartz J.J., Barzegar S., De Agostini A.I., Post M.J., Rosenberg R.D., Shworak N.W. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J. Clin. Invest. 2003, 111:989-999.
36. Hasegawa H., Wang F. Visualizing mechanosensory endings of TrkC-expressing neurons in HS3ST-2-hPLAP mice. J. Comp. Neurol. 2008, 511:543-556.
37. Hirano K., Sasaki N., Ichimiya T., Miura T., Van Kuppevelt T.H., Nishihara S. 3-O-Sulfated heparan sulfate recognized by the antibody HS4C3 contribute to the differentiation of mouse embryonic stem cells via Fas signaling. PLoS ONE 2012, 7:e43440.
38. Höök M., Bjork I., Hopwood J., Lindahl U. Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett. 1976, 66:90-93.
39. Hopwood J., Höök M., Linker A., Lindahl U. Anticoagulant activity of heparin: isolation of antithrombin-binding sites. FEBS Lett. 1976, 69:51-54.
40. Horner A.A. Rat heparan sulphates. A study of the antithrombin-binding properties of heparan sulphate chains from rat adipose tissue, brain, carcase, heart, intestine, kidneys, liver, lungs, skin and spleen. Biochem. J. 1990, 266:553-559.
41. Hu Y.P., Lin S.Y., Huang C.Y., Zulueta M.M., Liu J.Y., Chang W., Hung S.C. Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction. Nat. Chem. 2011, 3:557-563.
42. Huntington J.A., Olson S.T., Fan B.Q., Gettins P.G.W. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding. Biochemistry 1996, 35:8495-8503.
43. Irie A., Habuchi H., Kimata K., Sanai Y. Heparan sulfate is required for bone morphogenetic protein-7 signaling. Biochem. Biophys. Res. Commun. 2003, 308:858-865.
44. Jiang Y., Dunbar A., Gondek L.P., Mohan S., Rataul M., O'Keefe C., Sekeres M., Saunthararajah Y., Maciejewski J.P. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 2009, 113:1315-1325.
45. Jin L., Abrahams J.P., Skinner R., Petitou M., Pike R.N., Carrell R.W. The anticoagulant activation of antithrombin by heparin. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:14683-14688.
46. Joubert B.R., Lange E.M., Franceschini N., Mwapasa V., North K.E., Meshnick S.R. A whole genome association study of mother-to-child transmission of HIV in Malawi. Genome Med. 2010, 2:17.
47. Kailemia M.J., Li L., Xu Y., Liu J., Linhardt R.J., Amster I.J. Structurally informative tandem mass spectrometry of highly sulfated natural and chemoenzymatically synthesized heparin and heparan sulfate glycosaminoglycans. Mol. Cell. Proteomics 2013, 12:979-990.
48. Kakuta Y., Sueyoshi T., Negishi M., Pedersen L.C. Crystal structure of the sulfotransferase domain of human heparan sulfate N-deacetylase/N-sulfotransferase 1. J. Biol. Chem. 1999, 274:10673-10676.
49. Kakuta Y., Li L., Pedersen L.C., Pedersen L.G., Negishi M. Heparan sulphate N-sulphotransferase activity: reaction mechanism and substrate recognition. Biochem. Soc. Trans. 2003, 31:331-334.
50. Kamimura K., Rhodes J.M., Ueda R., McNeely M., Shukla D., Kimata K., Spear P.G., Shworak N.W., Nakato H. Regulation of Notch signaling by Drosophila heparan sulfate 3-O sulfotransferase. J. Cell Biol. 2004, 166:1069-1079.
51. Koide T., Odani S., Takahashi K., Ono T., Sakuragawa N. Antithrombin III Toyama: replacement of arginine-47 by cysteine in hereditary abnormal antithrombin III that lacks heparin-binding ability. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:289-293.
52. Kojima T., Leone C.W., Marchildon G.A., Marcum J.A., Rosenberg R.D. Isolation and characterization of heparan sulfate proteoglycans produced by cloned rat microvascular endothelial cells. J. Biol. Chem. 1992, 267:4859-4869.
53. Kowalewski B., Lamanna W.C., Lawrence R., Damme M., Stroobants S., Padva M., Kalus I., Frese M.A., Lubke T., Lullmann-Rauch R., D'Hooge R., Esko J.D., Dierks T. Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:10310-10315.
54. Krenn E.C., Wille I., Gesslbauer B., Poteser M., van Kuppevelt T.H., Kungl A.J. Glycanogenomics: a qPCR-approach to investigate biological glycan function. Biochem. Biophys. Res. Commun. 2008, 375:297-302.
55. Kreuger J., Spillmann D., Li J.P., Lindahl U. Interactions between heparan sulfate and proteins: the concept of specificity. J. Cell Biol. 2006, 174:323-327.
56. Kuberan B., Lech M.Z., Beeler D.L., Wu Z.L., Rosenberg R.D. Enzymatic synthesis of antithrombin III-binding heparan sulfate pentasaccharide. Nat Biotechnol. 2003, 21:1343-1346.
57. Kuberan B., Lech M., Borjigin J., Rosenberg R.D. Light-induced 3-O-sulfotransferase expression alters pineal heparan sulfate fine structure. A surprising link to circadian rhythm. J. Biol. Chem. 2004, 279:5053-5054.
58. Kusche M., Bäckström G., Riesenfeld J., Petitou M., Chaoy J., Lindahl U. Biosynthesis of heparin. O-Sulfation of the antithrombin-binding region. J. Biol. Chem. 1988, 263:15474-15484.
59. Lam L.H., Silbert J.E., Rosenberg R.D. The separation of active and inactive forms of heparin. Biochem. Biophys. Res. Commun. 1976, 69:570-577.
60. Lane D.A., Kunz G., Olds R.J., Thein S.L. Molecular genetics of antithrombin deficiency. Blood Rev. 1996, 10:59-74.
61. Langeslay D.J., Young R.P., Beni S., Beecher C.N., Mueller L.J., Larive C.K. Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra. Glycobiology 2012, 22:1173-1182.
62. Lawrence R., Yabe T., Hajmohammadi S., Rhodes J., McNeely M., Liu J., Lamperti E.D., Toselli P.A., Lech M., Spear P.G., Rosenberg R.D., Shworak N.W. The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues. Matrix Biol. 2007, 26:442-455.
63. Lawrence R., Lu H., Rosenberg R.D., Esko J.D., Zhang L. Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans. Nat. Methods 2008, 5:291-292.
64. Leder I.G. A novel 3-O sulfatase from human urine acting on methyl-2-deoxy-2-sulfamino-alphs-d-glucopyranoside 3-sulfate. Biochem. Biophys. Res. Commun. 1980, 94:1183-1189.
65. Li W., Johnson D.J., Esmon C.T., Huntington J.A. Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat. Struct. Mol. Biol. 2004, 11:857-862.
66. Linhardt R.J., Fitzgerald G.L., Cooney C.L., Langer R. Mode of action of heparin lyase on heparin. Biochimica et biophysica acta. 1982, 702:197-203.
67. Lindahl U., Li J.P. Interactions between heparan sulfate and proteins-design and functional implications. Int. Rev. Cell Mol. Biol. 2009, 276:105-159.
68. Lindahl U., Backstrom G., Höök M., Thunberg L., Fransson L.A., Linker A. Structure of the antithrombin-binding site in heparin. Proc. Natl. Acad. Sci. U. S. A. 1979, 76:3198-3202.
69. Lindahl U., Backstrom G., Thunberg L., Leder I.G. Evidence for a 3-O-sulfated d-glucosamine residue in the antithrombin-binding sequence of heparin. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:6551-6555.
70. Lindahl U., Backstrom G., Thunberg L. The antithrombin-binding sequence in heparin. Identification of an essential 6-O-sulfate group. J. Biol. Chem. 1983, 258:9826-9830.
71. Liu J., Pedersen L.C. Anticoagulant heparan sulfate: structural specificity and biosynthesis. Appl. Microbiol. Biotechnol. 2007, 74:263-272.
72. Liu J., Shworak N.W., Fritze L.M.S., Edelberg J.M., Rosenberg R.D. Purification of heparan sulfate d-glucosaminyl 3-O-sulfotransferase. J. Biol. Chem. 1996, 271:27072-27082.
73. Liu J., Shworak N.W., Sinay P., Schwartz J.J., Zhang L., Fritze L.M., Rosenberg R.D. Expression of heparan sulfate d-glucosaminyl 3-O-sulfotransferase isoforms reveals novel substrate specificities. J. Biol. Chem. 1999, 274:5185-5192.
74. Liu J.A., Shriver Z., Blaiklock P., Yoshida K., Sasisekharan R., Rosenberg R.D. Heparan sulfate d-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues. J. Biol. Chem. 1999, 274:38155-38162.
75. Liu J., Shriver Z., Pope R.M., Thorp S.C., Duncan M.B., Copeland R.J., Raska C.S., Yoshida K., Eisenberg R.J., Cohen G., Linhardt R.J., Sasisekharan R. Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D. J. Biol. Chem. 2002, 277:33456-33467.
76. Liu R., Xu Y., Chen M., Weiwer M., Zhou X., Bridges A.S., DeAngelis P.L., Zhang Q., Linhardt R.J., Liu J. Chemoenzymatic design of heparan sulfate oligosaccharides. J Biol Chem. 2010, 285:34240-34249.
77. Luo Y., Ye S., Kan M., McKeehan W.L. Structural specificity in a FGF7-affinity purified heparin octasaccharide required for formation of a complex with FGF7 and FGFR2IIIb. J. Cell. Biochem. 2006, 97:1241-1258.
78. Mahapatra S., Klee E.W., Young C.Y., Sun Z., Jimenez R.E., Klee G.G., Tindall D.J., Donkena K.V. Global methylation profiling for risk prediction of prostate cancer. Clin. Cancer Res. 2012, 18:2882-2895.
79. Marcum J.A., Rosenberg R.D. Heparinlike molecules with anticoagulant activity are synthesized by cultured endothelial cells. Biochem. Biophys. Res. Commun. 1985, 126:365-372.
80. Marcum J.A., Fritze L., Galli S.J., Karp G., Rosenberg R.D. Microvascular heparin-like species with anticoagulant activity. Am. J. Physiol. 1983, 245:H725-H733.
81. Marcum J.A., Atha D.H., Fritze L.M., Nawroth P., Stern D., Rosenberg R.D. Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J. Biol. Chem. 1986, 261:7507-7517.
82. Marcum J.A., Conway E.M., Youssoufian H., Rosenberg R.D. Anticoagulantly active heparin-like molecules from cultured fibroblasts. Exp. Cell Res. 1986, 166:253-258.
83. Martin-Subero J.I., Ammerpohl O., Bibikova M., Wickham-Garcia E., Agirre X., Alvarez S., Bruggemann M., Bug S., Calasanz M.J., Deckert M., Dreyling M., Du M.Q., Durig J., Dyer M.J., Fan J.B., Gesk S., Hansmann M.L., Harder L., Hartmann S., Klapper W., Kuppers R., Montesinos-Rongen M., Nagel I., Pott C., Richter J., Roman-Gomez J., Seifert M., Stein H., Suela J., Trumper L., Vater I., Prosper F., Haferlach C., Cruz Cigudosa J., Siebert R. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS One 2009, 4:e6986.
84. McKeehan W.L., Wu X.C., Kan M. Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex. J. Biol. Chem. 1999, 274:21511-21514.
85. Medeiros G.F., Mendes A., Castro R.A.B., Baú E.C., Nader H.B., Dietrich C.P. Distribution of sulfated glycosaminoglycans in the animal kingdom: widespread occurrence of heparin-like compounds in invertebrates. Biochim. Biophys. Acta Gen. Subj. 2000, 1475:287-294.
86. Meissen J.K., Sweeney M.D., Girardi M., Lawrence R., Esko J.D., Leary J.A. Differentiation of 3-O-sulfated heparin disaccharide isomers: identification of structural aspects of the heparin CCL2 binding motif. J. Am. Soc. Mass Spectrom. 2009, 20:652-657.
87. Mertens G., Cassiman J.J., Van den Berghe H., Vermylen J., David G. Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J. Biol. Chem. 1992, 267:20435-20443.
88. Meyer B., Thunberg L., Lindahl U., Larm O., Leder I.G. The antithrombin-binding sequence of heparin studied by n.m.r. spectroscopy. Carbohydr. Res. 1981, 88:C1-C4.
89. Midorikawa Y., Ishikawa S., Iwanari H., Imamura T., Sakamoto H., Miyazono K., Kodama T., Makuuchi M., Aburatani H. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer 2003, 103:455-465.
90. Miyamoto K., Asada K., Fukutomi T., Okochi E., Yagi Y., Hasegawa T., Asahara T., Sugimura T., Ushijima T. Methylation-associated silencing of heparan sulfate d-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene 2003, 22:274-280.
91. Mochizuki H., Yoshida K., Gotoh M., Sugioka S., Kikuchi N., Kwon Y.D., Tawada A., Maeyama K., Inaba N., Hiruma T., Kimata K., Narimatsu H. Characterization of a heparan sulfate 3-O-sulfotransferase-5, an enzyme synthesizing a tetrasulfated disaccharide. J. Biol. Chem. 2003, 278:26780-26787.
92. Mochizuki H., Yoshida K., Shibata Y., Kimata K. Tetrasulfated disaccharide unit in heparan sulfate: enzymatic formation and tissue distribution. J. Biol. Chem. 2008, 283:31237-31245.
93. Moon A.F., Edavettal S.C., Krahn J.M., Munoz E.M., Negishi M., Linhardt R.J., Liu J., Pedersen L.C. Structural analysis of the sulfotransferase (3-o-sulfotransferase isoform 3) involved in the biosynthesis of an entry receptor for herpes simplex virus 1. J. Biol. Chem. 2004, 279:45185-45193.
94. Moon A.F., Xu Y., Woody S.M., Krahn J.M., Linhardt R.J., Liu J., Pedersen L.C. Dissecting the substrate recognition of 3-O-sulfotransferase for the biosynthesis of anticoagulant heparin. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:5265-5270.
95. Neugebauer J.M., Cadwallader A.B., Amack J.D., Bisgrove B.W., Yost H.J. Differential roles for 3-OSTs in the regulation of cilia length and motility. Development 2013, 140:3892-3902.
96. Nguyen T.K., Arungundram S., Tran V.M., Raman K., Al-Mafraji K., Venot A., Boons G.J., Kuberan B. A synthetic heparan sulfate oligosaccharide library reveals the novel enzymatic action of d-glucosaminyl 3-O-sulfotransferase-3a. Mol. Biosyst. 2012, 8:609-614.
97. Nordenman B., Danielsson A., Bjork I. The binding of low-affinity and high-affinity heparin to antithrombin. Fluorescence studies. Eur. J. Biochem. 1978, 90:1-6.
98. O'Donnell C.D., Tiwari V., Oh M.J., Shukla D. A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread. Virology 2006, 346:452-459.
99. O'Reilly M.S., Pirie-Shepherd S., Lane W.S., Folkman J. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. Science 1999, 285:1926-1928.
100. Ori A., Wilkinson M.C., Fernig D.G. The heparanome and regulation of cell function: structures, functions and challenges. Front. Biosci. 2008, 13:4309-4338.
101. Ototani N., Kikuchi M., Yosizawa Z. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies. Biochem J. 1982, 205:23-30.
102. Pejler G., Danielsson I., Björk U., Lindahl H.B.Nader, Dietrich C.P. Structure and antithrombin-binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela mactroides. J. Biol. Chem. 1987, 262:11413-11421.
103. Pejler G., Bäckström G., Lindahl U., Paulsson M., Dziadek M., Fujiwara S., Timpl R. Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans. J. Biol. Chem. 1987, 262:5036-5043.
104. Pempe E.H., Xu Y., Gopalakrishnan S., Liu J., Harris E.N. Probing structural selectivity of synthetic heparin binding to stabilin protein receptors. J. Biol. Chem. 2012, 287:20774-20783.
105. Princivalle M., Hasan S., Hosseini G., de Agostini A.I. Anticoagulant heparan sulfate proteoglycans expression in the rat ovary peaks in preovulatory granulosa cells. Glycobiology 2001, 11:183-194.
106. Razi N., Lindahl U. Biosynthesis of heparin/heparan sulfate. The d-glucosaminyl 3-O-sulfotransferase reaction: target and inhibitor saccharides. J. Biol. Chem. 1995, 270:11267-11275.
107. Richard B., Swanson R., Olson S.T. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation. J. Biol. Chem. 2009, 284:27054-27064.
108. Riesenfeld J., Thunberg L., Höök M., Lindahl U. The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups. J. Biol. Chem. 1981, 256:2389-2394.
109. Rosenberg R.D., Damus P.S. The purification and mechanism of action of human antithrombin-heparin cofactor. J. Biol. Chem. 1973, 248:6490-6505.
110. Samson S.C., Ferrer T., Jou C.J., Sachse F.B., Shankaran S.S., Shaw R.M., Chi N.C., Tristani-Firouzi M., Yost H.J. 3-OST-7 Regulates BMP-Dependent Cardiac Contraction. PLoS biology. 2013, 11:e1001727.
111. Schedin-Weiss S., Richard B., Hjelm R., Olson S.T. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence. Biochemistry 2008, 47:13610-13619.
112. Scully M.F., Ellis V., Kakkar V.V. Heparan sulphate with no affinity for antithrombin III and the control of haemostasis. FEBS Lett. 1988, 241:11-14.
113. Shivapurkar N., Sherman M.E., Stastny V., Echebiri C., Rader J.S., Nayar R., Bonfiglio T.A., Gazdar A.F., Wang S.S. Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol. Oncol. 2007, 107:549-553.
114. Shively J.E., Conrad H.E. Formation of anhydrosugars in the chemical depolymerization of heparin. Biochemistry 1976, 15:3932-3942.
115. Shriver Z., Sundaram M., Venkataraman G., Fareed A., Linhardt R., Biemann K., Sasisekharan R. Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:10365-10370.
116. Shukla D., Liu J., Blaiklock P., Shworak N.W., Bai X.M., Esko J.D., Cohen G.H., Eisenberg R.J., Rosenberg R.D., Spear P.G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 1999, 99:13-22.
117. Shworak N.W., Liu J., Fritze L.M.S., Schwartz J.J., Zhang L.J., Logeart D., Rosenberg R.D. Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate d-glucosaminyl 3-O-sulfotransferase. J. Biol. Chem. 1997, 272:28008-28019.
118. Shworak N.W., Liu J.A., Petros L.M., Zhang L.J., Kobayashi M., Copeland N.G., Jenkins N.A., Rosenberg R.D. Multiple isoforms of heparan sulfate d-glucosaminyl 3-O-sulfotransferase-isolation, characterization, and expression of human cDNAs and identification of distinct genomic loci. J. Biol. Chem. 1999, 274:5170-5184.
119. Shworak N.W., Kobayashi T., de Agostini A., Smits N.C. Anticoagulant heparan sulfate to not clot-or not?. Prog. Mol. Biol. Transl. Sci. 2010, 93:153-178.
120. Streusand V.J., Bjork I., Gettins P.G., Petitou M., Olson S.T. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement. J. Biol. Chem. 1995, 270:9043-9051.
121. Takeda K., Hashimoto K., Uchikawa R., Tegoshi T., Yamada M., Arizono N. Direct effects of IL-4/IL-13 and the nematode Nippostrongylus brasiliensis on intestinal epithelial cells in vitro. Parasite Immunol. 2010, 32:420-429.
122. Tecle E., Diaz-Balzac C.A., Bulow H.E. Distinct 3-O-sulfated heparan sulfate modification patterns are required for kal-1-dependent neurite branching in a context-dependent manner in Caenorhabditis elegans. G3 (Bethesda) 2013, 3:541-552.
123. Ten Dam G.B., Kurup S., van de Westerlo E.M., Versteeg E.M., Lindahl U., Spillmann D., van Kuppevelt T.H. 3-O-Sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J. Biol. Chem. 2006, 281:4654-4662.
124. Thunberg L., Bäckström G., Lindahl U. Further characterization of the antithrombin-binding sequence in heparin. Carbohydr. Res. 1982, 100:393-410.
125. Tiwari V., O'Donnell C.D., Oh M.J., Valyi-Nagy T., Shukla D. A role for 3-O-sulfotransferase isoform-4 in assisting HSV-1 entry and spread. Biochem. Biophys. Res. Commun. 2005, 338:930-937.
126. Tiwari V., Clement C., Xu D., Valyi-Nagy T., Yue B.Y., Liu J., Shukla D. Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts. J. Virol. 2006, 80:8970-8980.
127. Tsuda H., Yamada S.H., Yamane Y., Yoshida K., Hopwood J.J., Sugahara K. Structures of five sulfated hexasaccharides prepared from porcine intestinal heparin using bacterial heparinase - Structural variants with apparent biosynthetic precursor-product relationships for the antithrombin III-binding site. J Biol Chem. 1996, 271:10495-10502.
128. Vanpouille C., Deligny A., Delehedde M., Denys A., Melchior A., Lienard X., Lyon M., Mazurier J., Fernig D.G., Allain F. The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue. J. Biol. Chem. 2007, 282:24416-24429.
129. Viskov C., Elli S., Urso E., Gaudesi D., Mourier P., Herman F., Boudier C., Casu B., Torri G., Guerrini M. Heparin dodecasaccharide containing two antithrombin-binding pentasaccharides: structural features and biological properties. J Biol Chem. 2013, 288:25895-25907.
130. Wiedermann Ch J., Romisch J. The anti-inflammatory actions of antithrombin-a review. Acta Med. Austriaca 2002, 29:89-92.
131. Wood M.W., Breitschwerdt E.B., Gookin J.L. Autocrine effects of interleukin-6 mediate acute-phase proinflammatory and tissue-reparative transcriptional responses of canine bladder mucosa. Infect. Immun. 2011, 79:708-715.
132. Wu Z.L., Lech M., Beeler D.L., Rosenberg R.D. Determining heparan sulfate structure in the vicinity of specific sulfotransferase recognition sites by mass spectrometry. J. Biol. Chem. 2004, 279:1861-1866.
133. Xia G.Q., Chen J.H., Tiwari V., Ju W.J., Li J.P., Malmström A., Shukla D., Liu J. Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1. J. Biol. Chem. 2002, 277:37912-37919.
134. Xu D., Esko J.D. Demystifying heparan sulfate-binding proteins. Annu. Rev. Biochem. Vol. 2014, (83). (in press).
135. Xu D., Tiwari V., Xia G., Clement C., Shukla D., Liu J. Characterization of heparan sulphate 3-O-sulphotransferase isoform 6 and its role in assisting the entry of herpes simplex virus type 1. Biochem. J. 2005, 385:451-459.
136. Xu D., Moon A.F., Song D., Pedersen L.C., Liu J. Engineering sulfotransferases to modify heparan sulfate. Nat. Chem. Biol. 2008, 4:200-202.
137. Xu Y., Masuko S., Takieddin M., Xu H., Liu R., Jing J., Mousa S.A., Linhardt R.J., Liu J. Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. Science 2011, 334:498-501.
138. Xu Y., Pempe E.H., Liu J. Chemoenzymatic synthesis of heparin oligosaccharides with both anti-factor Xa and anti-factor IIa activities. J. Biol. Chem. 2012, 287:29054-29061.
139. Yabe T., Hata T., He J., Maeda N. Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain. Glycobiology 2005, 15:982-993.
140. Yamada S., Yoshida K., Sugiura M., Sugahara K., Khoo K.H., Morris H.R., Dell A. Structural studies on the bacterial lyase-resistant tetrasaccharides derived from the antithrombin III-binding of porcine intestinal heparin. J. Biol. Chem. 1993, 268:4780-4787.
141. Ye S., Luo Y.D., Lu W.Q., Jones R.B., Linhardt R.J., Capila I., Toida T., Kan M., Pelletier H., McKeehan W.L. Structural basis for interaction of FGF-1, FGF-2, and FGF-7 with different heparan sulfate motifs. Biochemistry 2001, 40:14429-14439.
142. Yoon M., Zago A., Shukla D., Spear P.G. Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, Nectin-2, and 3-O-sulfated heparan sulfate but not with Nectin-1. J. Virol. 2003, 77:9221-9231.
143. Zhang L.J., Schwartz J.J., Miller J., Liu J., Fritze L.M.S., Shworak N.W., Rosenberg R.D. The retinoic acid and cAMP-dependent up-regulation of 3-O-sulfotransferase-1 leads to a dramatic augmentation of anticoagulantly active heparan sulfate biosynthesis in F9 embryonal carcinoma cells. J. Biol. Chem. 1998, 273:27998-28003.
144. Zhang L.J., Yoshida K., Liu J., Rosenberg R.D. Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells. J. Biol. Chem. 1999, 274:5681-5691.
145. Zhang L.J., Beeler D.L., Lawrence R., Lech M., Liu J., Davis J.C., Shriver Z., Sasisekharan R., Rosenberg R.D. 6-O-Sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J. Biol. Chem. 2001, 276:42311-42321.
146. Zhang L.J., Lawrence R., Schwartz J.J., Bai X.M., Wei G., Esko J.D., Rosenberg R.D. The effect of precursor structures on the action of glucosaminyl 3-O-sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate. J. Biol. Chem. 2001, 276:28806-28813.
147. Zhang W., Swanson R., Izaguirre G., Xiong Y., Lau L.F., Olson S.T. The heparin-binding site of antithrombin is crucial for antiangiogenic activity. Blood 2005, 106:1621-1628.
148. Zhang Z., Liu X., Chen J., Su H., Luo Q., Ye J., Tang N., Zhang W., Chen W., Ko B.C., Huang A. Heparin sulphate d-glucosaminyl 3-O-sulfotransferase 3B1 plays a role in HBV replication. Virology 2010, 406:280-285.
149. Zhao W., Garron M.L., Yang B., Xiao Z., Esko J.D., Cygler M., Linhardt R.J. Asparagine 405 of heparin lyase II prevents the cleavage of glycosidic linkages proximate to a 3-O-sulfoglucosamine residue. FEBS Lett. 2011, 585:2461-2466.